Michael Rosol | CMO |
Erika Eves | VP, Finance & Administration |
Michael Okunewitch | Maxim Group |
Welcome to the Navidea Biopharmaceuticals First Quarter 2022 Earnings Call and Business Update. I will now turn the call over to the Chief Medical Officer from Navidea, Michael Rosol, you may begin.
Thank you, and thank you all for joining us for today's earning call. This call is being webcast live on our website, ir.navidea.com and a replay will be made available.
Following prepared remarks, we will be conducting a live Q&A session.